Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to -$10.6 billion.

  • Bristol Myers Squibb's Enterprise Value rose 153.62% to -$10.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$10.6 billion, marking a year-over-year increase of 153.62%. This contributed to the annual value of -$10.6 billion for FY2025, which is 153.62% up from last year.
  • As of Q4 2025, Bristol Myers Squibb's Enterprise Value stood at -$10.6 billion, which was up 153.62% from -$16.5 billion recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Enterprise Value peaked at -$6.6 billion during Q2 2024, and registered a low of -$16.9 billion during Q4 2021.
  • Over the past 5 years, Bristol Myers Squibb's median Enterprise Value value was -$11.3 billion (recorded in 2024), while the average stood at -$11.5 billion.
  • Per our database at Business Quant, Bristol Myers Squibb's Enterprise Value surged by 4560.51% in 2022 and then plummeted by 10531.9% in 2025.
  • Bristol Myers Squibb's Enterprise Value (Quarter) stood at -$16.9 billion in 2021, then skyrocketed by 45.61% to -$9.2 billion in 2022, then crashed by 32.94% to -$12.2 billion in 2023, then rose by 11.61% to -$10.8 billion in 2024, then increased by 1.54% to -$10.6 billion in 2025.
  • Its Enterprise Value was -$10.6 billion in Q4 2025, compared to -$16.5 billion in Q3 2025 and -$13.5 billion in Q2 2025.